| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |